# Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema

> **NCT03026946** · PHASE3 · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 76 (estimated)

## Conditions studied

- Hand Eczema

## Interventions

- **DRUG:** Alitretinoin
- **DRUG:** cyclosporin A

## Key facts

- **NCT ID:** NCT03026946
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-29
- **Primary completion:** 2022-07
- **Final completion:** 2022-07
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03026946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03026946, "Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03026946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*